Scope
Reference
SC13798-25
Description
The University of Birmingham invites tenders for supply of investigational medicinal product matched placebo. The University requires the purchase of the drug Apixaban, provision of a matched placebo, repackaging, labelling, distribution and delivery of tablets for a blinded randomised control trial.
Total value (estimated)
- £500,000 excluding VAT
- £600,000 including VAT
Above the relevant threshold
Contract dates (estimated)
- 1 September 2025 to 31 July 2028
- 2 years, 11 months
Main procurement category
Services
CPV classifications
- 71900000 - Laboratory services
Contract locations
- UKC - North East (England)
- UKD - North West (England)
- UKE - Yorkshire and the Humber
- UKF - East Midlands (England)
- UKG - West Midlands (England)
- UKH - East of England
- UKI - London
- UKJ - South East (England)
- UKK - South West (England)
Engagement
Engagement deadline
20 November 2024
The engagement was carried out before this notice was published.
Engagement process description
The clinical trials team conducted a request for quotation process to scope out potential costs. Several quotes were received back and due to the overall estimated value a decision was made to conduct an open tender process.
Participation
Particular suitability
Small and medium-sized enterprises (SME)
Submission
Publication date of tender notice (estimated)
26 April 2025
Contracting authority
THE UNIVERSITY OF BIRMINGHAM
- Companies House: RC000645
- Public Procurement Organisation Number: PHCQ-3464-LVTM
Edgbaston
Birmingham
B15 2TT
United Kingdom
Email: procurement@bham.ac.uk
Website: http://www.birmingham.ac.uk
Region: UKG31 - Birmingham
Organisation type: Public authority - sub-central government